
1.18 Delayed Data As of May 24 | ![]() Today’s Change | 1.08 Today|||52-Week Range 8.10 | -70.77% Year-to-Date |
Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates May 12 / Zacks.com - Paid Partner Content |
Previous close | 1.23 |
Today’s open | 1.24 |
Day’s range | 1.14 - 1.33 |
Volume | 70,250 |
Average volume (3 months) | 75,788 |
Market cap | $10.5M |
Earnings growth (last year) | +37.88% |
Earnings growth (this year) | +31.72% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | +367.40% |
P/E ratio | NM |
Price/Sales | 4.13 |
Price/Book | 0.86 |
Today’s change | Today’s % change | |
---|---|---|
ZSANZosano Pharma Corp | -0.14 | -6.57% |
KTRAKintara Therapeutics... | -0.01 | -4.85% |
BLPHBellerophon Therapeu... | -0.02 | -1.55% |
XBIOXenetic Biosciences ... | -0.01 | -0.95% |
Next reporting date | August 11, 2022 |
EPS forecast (this quarter) | -$0.32 |
Annual revenue (last year) | $9.0M |
Annual profit (last year) | -$14.3M |
Net profit margin | -158.25% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Stony Brook, New York |